Treating tumour-bearing animals with the mTORC1/2 inhibitor AZD2014 (vistusertib) reduces growth of the PTEN-null renal tumour xenograft 786-0 (Zheng et al., 2015; Lynch et al., 2018). Here, PTEN is linked to neoplasm.